Skip to main content
. 2017 Jul 11;8:456. doi: 10.3389/fphar.2017.00456

FIGURE 1.

FIGURE 1

The effect of RosA on cardiac function in rat I/R model. The effect of RosA on LVDP (A), dp/dtmax (B), dp/dtmin (C), and CF (D) in rat hearts. Control, healthy control mice; I/R, ischemia/reperfusion model mice; RosA, healthy mice treated with RosA; PIO, healthy mice treated with pioglitazone; GW9662, healthy mice treated with GW9662; T0070907, healthy mice treated with T0070907; RosA+I/R, I/R mice treated with RosA; PIO+I/R, I/R mice treated with PIO; RosA+GW9662+I/R, I/R mice treated with RosA plus GW9662; RosA+T0070907+I/R, I/R mice treated with RosA plus T0070907; PIO+GW9662+I/R, I/R mice treated with PIO plus GW9662; PIO+T0070907+I/R, I/R mice treated with PIO plus T0070907. Values are presented as means with their standard deviation, n = 6. Compared with the control group, #P < 0.05, ##P < 0.01. Compared with the I/R group, P < 0.05, ∗∗P < 0.01. Compared with the I/R+RosA group, $P < 0.05, $$P < 0.01. Compared with the I/R+PIO group, &P < 0.05, &&P < 0.01.